EF Hutton Maintains Buy on Can Fite Biofarma, Maintains $10 Price Target

Benzinga · 08/30 19:10
EF Hutton analyst Jason Kolbert maintains Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $10 price target.